Nifty Pharma Today: Index Rises 0.75% to 26,675.50

Quick sector takeaways

• Nifty Pharma closed 0.75% higher at 26,675.50, up 197.40 points from its previous close of 26,478.10.
• The sector led India’s NSE sector indices for the session, while 12 of its 20 stocks advanced and eight declined.
• Zydus Lifesciences, Divi’s Laboratories, Granules India and Laurus Labs were among the leading gainers, while JB Chemicals & Pharmaceuticals and Biocon declined.
• For the next session, investors can watch whether the index holds near 26,675.50 and whether positive participation remains broader than the declines.

Nifty Pharma today: end-of-session wrap

Nifty Pharma today delivered the strongest sectoral performance at the closing bell on 7 September 2026. The index ended at 26,675.50, gaining 197.40 points, or 0.75%, over the previous close of 26,478.10. The finish reflected a positive session for the pharma basket, with gains across a majority of its stocks.

The index opened at 26,472.85 and stayed above its previous close through the session. It climbed to an intraday high of 26,711.20 before closing only 35.70 points below that mark. This placed the close in the upper part of the day’s range, an observation that underscores the sector’s firm end-of-session position.

For a broader market update, visit Univest Market View.

Price snapshot

Nifty Pharma began the day at 26,472.85, marginally below the previous close of 26,478.10. The index then traded between 26,440.40 and 26,711.20, a range of 270.80 points. Its closing level of 26,675.50 was 235.10 points above the day’s low and 202.65 points above the opening level.

The 0.75% rise was the session’s strongest percentage gain among the sector indices tracked here. The closing level also marked a clear improvement from the prior session’s 26,478.10, while the day’s high shows that buying interest carried the index beyond 26,700 during trade.

Sector ranking

Nifty Pharma ranked as the top gaining sector index on 7 September 2026. The complete session ranking, from the strongest gain to the steepest fall, was as follows:

• Nifty Pharma: +0.75%.
• Nifty Auto: -0.04%.
• Nifty Mid Select: -0.43%.
• Nifty Financial Services: -0.44%.
• Nifty Bank: -0.49%.
• Nifty FMCG: -0.66%.
• Nifty Metal: -1.24%.
• Nifty IT: -2.28%.

This comparison places pharma distinctly ahead of the remaining indices, all of which ended lower. Nifty Auto was closest to unchanged, while Nifty IT recorded the sharpest percentage fall of the session.

Constituent breadth

Sector breadth was positive, with 12 Nifty Pharma stocks advancing and eight declining. There were no unchanged stocks. The advance-decline ratio stood at 1.5, meaning there were one-and-a-half advancing stocks for every declining stock.

That breadth reading adds context to the index’s 0.75% rise: the upward move was accompanied by gains across more than half of the sector’s stocks. At the same time, the eight declines show that performance within pharma remained differentiated rather than uniformly positive.

Heavyweights versus broader participation

Among prominent pharma names, Divi’s Laboratories rose 2.36% to ₹9,315.00 and Torrent Pharmaceuticals gained 1.17% to ₹4,914.00. Cipla added 0.72% to ₹1,395.00. In contrast, Sun Pharmaceutical Industries edged down 0.21% to ₹1,895.00, while Dr. Reddy’s Laboratories slipped 0.59% to ₹1,144.20.

The picture therefore combined strength in several major names with broader participation from other gainers. Divi’s Laboratories closed at its day high of ₹9,315.00, while Torrent Pharmaceuticals ended at ₹4,914.00, just ₹1 below its intraday high of ₹4,915.00.

Key Nifty Pharma stocks

Stock	Move	Why it matters
Zydus Lifesciences	+3.29% to ₹1,156.90	It was the strongest percentage gainer among the highlighted stocks.
Divi’s Laboratories	+2.36% to ₹9,315.00	It closed at its intraday high after a ₹215.00 gain.
Granules India	+2.24% to ₹867.30	Its advance added to the positive breadth across the sector.
JB Chemicals & Pharmaceuticals	-3.87% to ₹2,408.90	It was the sharpest percentage decliner in the sector.
Biocon	-1.51% to ₹391.40	Its decline was the second-largest among the highlighted losers.

Biggest positive movers

Zydus Lifesciences led the gainers with a 3.29% rise to ₹1,156.90, after trading between ₹1,114.10 and ₹1,163.00. Divi’s Laboratories followed with a 2.36% advance to ₹9,315.00. Granules India rose 2.24% to ₹867.30, while Laurus Labs gained 1.99% to ₹1,876.70 and closed at its day high. Gland Pharma added 1.43% to ₹2,974.30.

Biggest negative movers

JB Chemicals & Pharmaceuticals declined 3.87% to ₹2,408.90, despite touching a day high of ₹2,525.50 earlier in the session. Biocon fell 1.51% to ₹391.40. Dr. Reddy’s Laboratories, Abbott India and Mankind Pharma declined 0.59%, 0.48% and 0.43%, respectively. These moves tempered, but did not reverse, the sector’s overall positive close.

Stocks to watch next session

• Zydus Lifesciences: Watch whether it extends from ₹1,156.90 after its 3.29% gain.
• Divi’s Laboratories: Watch its position after closing at the day’s high of ₹9,315.00.
• Granules India: Watch whether it revisits its session high of ₹873.85 after closing at ₹867.30.
• Laurus Labs: Watch its follow-through after a 1.99% rise and a close at ₹1,876.70.
• JB Chemicals & Pharmaceuticals: Watch its movement after the session’s sharpest decline to ₹2,408.90.
• Sun Pharmaceutical Industries: Watch whether it moves from ₹1,895.00 after its modest 0.21% decline.

The constructive case

The constructive evidence in Nifty Pharma today is visible in three readings: the index outperformed every other sector index in the session, it closed 0.75% higher, and advancing stocks outnumbered declining stocks by 12 to eight. The close near the day’s high also provides a positive end-of-session observation.

Strength was not limited to one stock. Zydus Lifesciences, Divi’s Laboratories, Granules India, Laurus Labs, Gland Pharma, Ajanta Pharma and Torrent Pharmaceuticals all posted gains of more than 1%. This distribution supported the index’s leadership on the day.

The cautious case

The sector’s gain coexisted with eight declining stocks, including JB Chemicals & Pharmaceuticals, Biocon, Dr. Reddy’s Laboratories, Abbott India, Mankind Pharma, Ipca Laboratories, Lupin and Sun Pharmaceutical Industries. The breadth was positive, but it was not unanimous.

Investors may also note the difference between the index high of 26,711.20 and the close of 26,675.50. The index retained most of its intraday advance, yet it did not finish at the session peak. Next-session price action and breadth will offer the next reading on whether the day’s leadership broadens or remains selective.

Univest Insights

Nifty Pharma’s closing performance stood out because it was positive in a session where every other listed sector index ended in the red. Its 0.75% gain created a clear gap over Nifty Auto’s 0.04% decline and the larger falls in IT, Metal and FMCG.

The index’s intraday path was also notable. Starting at 26,472.85, it briefly dipped to 26,440.40 before advancing to 26,711.20. The closing position at 26,675.50 indicated that the index retained most of the recovery achieved during the session.

At stock level, the leading gains in Zydus Lifesciences and Divi’s Laboratories contrasted with the declines in JB Chemicals & Pharmaceuticals and Biocon. This divergence reinforces the value of following both the sector index and individual stock moves instead of viewing the sector as a single uniform trade.

For nifty pharma today, the next session’s key reading is whether the index sustains 26,675.50 while advancing stocks continue to outnumber declining stocks.

Published on 7 September 2026 at 4:15 PM IST

Know more with Univest

Log in to Univest to explore market insights, track stocks, and get 3 free trade ideas on Share Market Today.

Know More – Log In

Frequently asked questions

What was Nifty Pharma’s closing level on 7 September 2026?

Nifty Pharma closed at 26,675.50, up 197.40 points or 0.75% from the previous close of 26,478.10.

Why was Nifty Pharma the top gaining sector index?

Nifty Pharma rose 0.75%, while every other sector index in the session ranking ended lower.

What were Nifty Pharma’s intraday high and low?

The index recorded an intraday high of 26,711.20 and an intraday low of 26,440.40.

How was the breadth in Nifty Pharma stocks?

Twelve stocks advanced and eight declined, producing an advance-decline ratio of 1.5.

Which stocks were the top gainers in Nifty Pharma?

Zydus Lifesciences gained 3.29%, followed by Divi’s Laboratories at 2.36%, Granules India at 2.24% and Laurus Labs at 1.99%.

Which stock was the biggest loser in Nifty Pharma?

JB Chemicals & Pharmaceuticals was the biggest percentage loser, declining 3.87% to ₹2,408.90.

Disclaimer

Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.